Translate
Orchestra Biomed Holdings Inc.
About
Orchestra Biomed Holdings Inc. (NASDAQ:OBIO) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 23 2026
Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026
Mar 12 2026
Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
Mar 3 2026
Orchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at THT and CRT
Feb 13 2026
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jan 12 2026
Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics
Recent Videos
Cómo invertir en Orchestra Biomed Holdings In (OBIO)
Mar 26, 2026
My Key Takeaway from Orchestra BioMed's Compensation Filing
Feb 22, 2026
Orchestra BioMed Holdings, Inc. (OBIO) #AcquisitionOfVivasureByHaemonetics #PremarketApprovalFDA
Jan 21, 2026
My $21M Takeaway from Orchestra BioMed's 8-K Filing
Jan 18, 2026
Financials
Revenue
$33.48 M
Market Cap
$248.13 M
EPS
-1.11